These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 35470645)

  • 1.
    Khalid H; Khalid S; Sufyan M; Ashfaq UA
    Z Naturforsch C J Biosci; 2022 Nov; 77(11-12):473-482. PubMed ID: 35470645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel inhibitors of angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19).
    Upreti S; Prusty JS; Pandey SC; Kumar A; Samant M
    Mol Divers; 2021 Aug; 25(3):1795-1809. PubMed ID: 33398633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Identification and Analysis of Potentially Bioactive Antiviral Phytochemicals against SARS-CoV-2: A Molecular Docking and Dynamics Simulation Approach.
    Halder SK; Sultana I; Shuvo MN; Shil A; Himel MK; Hasan MA; Shawan MMAK
    Biomed Res Int; 2023; 2023():5469258. PubMed ID: 37214084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation.
    Gorla US; Rao K; Kulandaivelu US; Alavala RR; Panda SP
    Comb Chem High Throughput Screen; 2021; 24(6):879-890. PubMed ID: 32819226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytomedical compounds as promising therapeutic agents for COVID-19 targeting angiotensin-converting enzyme 2: a review.
    Amtaghri S; Slaoui M; Eddouks M
    J Pharm Pharmacol; 2024 Oct; 76(10):1239-1268. PubMed ID: 39018169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.
    Bondhon TA; Fatima A; Jannat K; Hasan A; Jahan R; Nissapatorn V; Wiart C; Pereira ML; Rahmatullah M
    Trop Biomed; 2021 Jun; 38(2):214-221. PubMed ID: 34172713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ensemble docking-based virtual screening and molecular dynamics simulation of phytochemical compounds from Malaysian Kelulut Honey (KH) against SARS-CoV-2 target enzyme, human angiotensin-converting enzyme 2 (ACE-2).
    Ismail CMKH; Abdul Hamid AA; Abdul Rashid NN; Lestari W; Mokhtar KI; Mustafa Alahmad BE; Abd Razak MRM; Ismail A
    J Biomol Struct Dyn; 2024 Jan; ():1-30. PubMed ID: 38279932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking.
    Joshi T; Joshi T; Sharma P; Mathpal S; Pundir H; Bhatt V; Chandra S
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4529-4536. PubMed ID: 32373991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of honey bee pollen constituents against COVID-19: an emerging hot spot in targeting SARS-CoV-2-ACE-2 interaction.
    Zarei A; Ramazani A; Rezaei A; Moradi S
    Nat Prod Res; 2023 Mar; 37(6):974-980. PubMed ID: 35758279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and in Silico Study of New Biscoumarin Glycosides from Paramignya trimera against Angiotensin-Converting Enzyme 2 (ACE-2) for Preventing SARS-CoV-2 Infection.
    Ha NX; Huong TT; Khanh PN; Hung NP; Loc VT; Ha VT; Quynh DT; Nghi DH; Hai PT; Scarlett CJ; Wessjohann LA; Cuong NM
    Chem Pharm Bull (Tokyo); 2024 Jun; 72(6):574-583. PubMed ID: 38866495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study.
    Kushwaha PP; Singh AK; Prajapati KS; Shuaib M; Gupta S; Kumar S
    Microb Pathog; 2021 Aug; 157():104954. PubMed ID: 34033891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytochemical rich Himalayan
    Lingwan M; Shagun S; Pahwa F; Kumar A; Verma DK; Pant Y; Kamatam LVK; Kumari B; Nanda RK; Sunil S; Masakapalli SK
    J Biomol Struct Dyn; 2023 Mar; 41(4):1403-1413. PubMed ID: 34961411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Antimalarial Phytochemicals be a Possible Cure for COVID-19? Molecular Docking Studies of Some Phytochemicals to SARS-CoV-2 3C-like Protease.
    Hasan A; Jannat K; Bondhon TA; Jahan R; Hossan MS; de Lourdes Pereira M; Nissapatorn V; Wiart C; Rahmatullah M
    Infect Disord Drug Targets; 2022; 22(1):e290721195143. PubMed ID: 34376138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease.
    Oso BJ; Olaoye IF; Omeike SO
    Arch Razi Inst; 2021; 76(3):453-459. PubMed ID: 34824739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an
    Pandey P; Rane JS; Chatterjee A; Kumar A; Khan R; Prakash A; Ray S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6306-6316. PubMed ID: 32698689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections.
    Junior AG; Tolouei SEL; Dos Reis Lívero FA; Gasparotto F; Boeing T; de Souza P
    Curr Pharm Des; 2021; 27(13):1588-1596. PubMed ID: 33459225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
    Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
    Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
    Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.